eureKING
A SPAC created to acquire European biomanufacturing companies.
KINGS | PA
Overview
Corporate Details
- ISIN(s):
- FR0014009ON9
- LEI:
- 96950078TLFWTM2QE234
- Country:
- France
- Address:
- 128 RUE LA BOETIE, 75008 PARIS
- Website:
- https://eureking.com
- Sector:
- Manufacturing
Description
eureKING is a Special Purpose Acquisition Company (SPAC) focused on the European healthcare sector, with a specific dedication to biomanufacturing. Founded in March 2022, the company's primary objective is to acquire and combine with European companies specializing in the production and manufacture of biopharmaceuticals. Through these strategic acquisitions, eureKING aims to build a leading European bio-CDMO (Contract Development and Manufacturing Organization). Its investment focus covers all stages of the biomanufacturing process, from clinical development through to commercialization and the full product lifecycle.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-11-28 20:03 |
Early dissolution, leading to liquidation of eureKING, approved by the sharehol…
|
English | 314.0 KB | ||
| 2023-11-28 20:03 |
Dissolution anticipée, entrainant la liquidation d’eureKING, approuvée par l’as…
|
French | 289.1 KB | ||
| 2023-11-24 17:50 |
Delisting of all financial instruments issued by the Company following the extr…
|
English | 254.8 KB | ||
| 2023-11-24 17:50 |
Radiation de la cote de l’ensemble des instruments financiers émis par la Socié…
|
French | 256.1 KB | ||
| 2023-11-06 21:14 |
Availability of the preparatory documents for the shareholders’ Extraordinary G…
|
English | 219.2 KB | ||
| 2023-11-06 21:14 |
Mise à disposition des documents préparatoires à l’assemblée générale extraordi…
|
French | 194.7 KB | ||
| 2023-10-12 18:56 |
eureKING will not complete its Proposed acquisitions of Skyepharma and SCTbio a…
|
English | 205.4 KB | ||
| 2023-10-12 18:56 |
eureKING annonce l’abandon de son projet d’acquisition de Skyepharma et de SCTb…
|
French | 198.7 KB | ||
| 2023-10-11 16:08 |
Franchissement de seuils
|
French | 200.3 KB | ||
| 2023-10-11 16:08 |
Franchissement de seuils
|
French | 200.6 KB | ||
| 2023-10-11 16:07 |
Franchissement de seuils et déclaration d'intention
|
French | 353.6 KB | ||
| 2023-10-09 07:35 |
Update on the Proposed IBC with Skyepharma and the Proposed Acquisition of SCTb…
|
English | 266.4 KB | ||
| 2023-10-09 07:35 |
Mise à jour sur l’IBC Proposé avec Skyepharma et l’Acquisition Proposée de SCTb…
|
French | 254.4 KB | ||
| 2023-10-04 08:48 |
Franchissement de seuils
|
French | 198.0 KB | ||
| 2023-10-03 11:00 |
Franchissement de seuils
|
French | 264.2 KB |
Automate Your Workflow. Get a real-time feed of all eureKING filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for eureKING
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for eureKING via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
